Project Type
independent
Project Start Date
10/01/2007
Project End Date
09/30/2012
Target Population(s)
TBI

This project is a placebo-controlled pilot study of the effects of dextroamphetamine (DEX) on attention, engagement in therapy, cognitive and motor speed, and other outcomes in subacute TBI. We will also examine the possibility that DEX accelerates the pace of functional recovery in the subacute phase.